Company Profile

Baxter International Inc. is a global diversified healthcare company that develops, manufactures and markets products to treat hemophilia, immune disorders, infectious diseases, cancer, kidney disease, trauma and other chronic and acute medical conditions. These products are used by hospitals, clinical and medical research laboratories, kidney dialysis centers, rehabilitation centers, nursing homes, doctors' offices and by patients at home under physician supervision.

Baxter manufactures products in 27 countries and sells them in over 100 countries, with more than half of its sales coming from outside of the United States. The company has subsidiaries in more than 40 countries. In other locations, sales are made through distributors. In 2006, sales totaled $10.4 billion globally. As of July 2007, Baxter employed approximately 45,000¹ people worldwide (see graph in Employees section).

¹At the end of 2006, Baxter employed approximately 48,000 employees worldwide, but sold its Transfusion Therapies business in February 2007.

"Baxter employees around the world are connected by their enduring commitment to save and sustain lives. It is this higher purpose that binds us as a company and as global citizens."

Robert L. Parkinson, Jr.
Baxter Chairman and Chief Executive Officer

View facility list

Baxter operates in a cost-competitive global healthcare marketplace heavily influenced by reimbursement for products and therapies. Baxter sales are growing fastest in developing markets, where economic growth leads to increased healthcare spending. Baxter's unique combination of expertise in medical devices, pharmaceuticals and biotechnology differentiates the company from others in the healthcare industry. While no single company competes with Baxter in all of its businesses, the company faces competition in each of its segments from international and domestic healthcare companies of all sizes.

Baxter operates in three business segments:

The BioScience business is a leading manufacturer of plasma-based and recombinant proteins to treat hemophilia. Other products include plasma-based therapies to treat immune disorders, alpha 1-antitrypsin deficiency and other chronic blood-related conditions; albumin, used to treat burns and shock; products for regenerative medicine, such as proteins used in hemostasis, wound-sealing and tissue regeneration; products used in adult stem-cell therapies; and vaccines.
The Medication Delivery business is a leading manufacturer of products used to deliver fluids and drugs to patients. These include intravenous (IV) solutions and administration sets, pre-mixed drugs and drug reconstitution systems, pre-filled vials and syringes for injectable drugs, and electronic infusion devices. The business also provides IV nutrition products, inhalation products for general anesthesia, contract manufacturing services, and drug formulation and packaging technologies.
The Renal business is a leading manufacturer of products for peritoneal dialysis (PD), a home therapy for people with irreversible kidney failure who require renal replacement therapy. These products include PD solutions and related supplies to help patients manually perform solution exchanges, as well as automated PD cyclers that provide therapy to patients overnight. The business also distributes products for hemodialysis, which is generally conducted in a hospital or clinic.

Baxter's products, facilities and operations are subject to regulation by the U.S. Food and Drug Administration (FDA) and other regulatory authorities worldwide. Baxter works with such authorities to develop and manufacture safe and effective products for its customers.

Sales by Business

Sales by Region